024: Identifying epigenetic markers predicting response to inhibition of CD95 signaling in glioblastoma

HIPO Investigator:

Prof. Wick

Prof. Wiestler

Supported by: POP

Entity: glioma

Publications:

Wick et al.; A phase II, randomized, study of weekly APG101+reirradiation versus reirradiation in progressive glioblastoma, Clin Cancer Res 2014

Wiestler B et al.; Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma, Acta Neuropathol. 2014

 

DKFZ Logo 3zu Research en Black Blue sRGB

4c nctlogo 2009

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.